The 10 Best (and Worst) Ways to Get New GLP-1 and Peptide Patients in 2026 — Now That the FDA Is Restricting Compounded Supply
The 10 Best (and Worst) Ways to Get New GLP-1 and Peptide Patients in 2026 — Now That the FDA Is Restricting Compounded Supply Every week in 2026 brings another headline about the FDA squeezing compounded GLP-1s — restricted ingredients, warning letters to telehealth sellers, a compounding advisory committee meeting on the calendar for July. […]